Clinical Trial Update: A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A placebo-controlled Phase 2 trial evaluated pregabalin (Lyrica) for irritable bowel syndrome. The study completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-07-14